demonstrated the oncogenic role of HIF-1α and HIF-2α in the initiation of ccRCC using a mouse ccRCC model and suggested that changes in the balance of HIF-1α and HIF-2α activity may influence different aspects of ccRCC biology and disease aggressiveness (40). Here, EPAS1 is linked to nonpapillary renal cell carcinoma.